Elaboration of new medicines for inhibition of NCp7 and hepatitis C viruses

dc.contributor.authorSafarov, S.
dc.contributor.authorKhalikova, M.
dc.contributor.authorKuznetsov, A. S.
dc.contributor.authorRadzha, M.
dc.contributor.authorSeley-Radtke, Katherine
dc.date.accessioned2025-07-30T19:22:40Z
dc.date.issued2017-11-22
dc.descriptionConference on Numanov's readings, 22 Nov 2017, Dushanbe (Tajikistan)
dc.description.abstractPresent article is devoted to elaboration of new medicines for inhibition of NCp7 and hepatitis C viruses. The process of synthesis of initial products has been described.
dc.description.urihttps://inis.iaea.org/records/dhsfn-3zw95
dc.format.extent4 pages
dc.genreconference papers and proceedings
dc.identifierdoi:10.13016/m2e9cx-9hwk
dc.identifier.citationSafarov, S., M. Khalikova, A. S. Kuznetsov, M. Radzha, and K. Seley-Radtke. “Elaboration of new medicines for inhibition of NCp7 and hepatitis C viruses.” In Conference “X IV Numanov’s readings” Proceedings, 196–99, 2017. https://inis.iaea.org/records/dhsfn-3zw95.
dc.identifier.urihttp://hdl.handle.net/11603/39582
dc.language.isoru
dc.publisherInternational Atomic Energy Agency
dc.relation.isAvailableAtThe University of Maryland, Baltimore County (UMBC)
dc.relation.ispartofUMBC Student Collection
dc.relation.ispartofUMBC Faculty Collection
dc.relation.ispartofUMBC Chemistry & Biochemistry Department
dc.rightsThis item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.
dc.titleElaboration of new medicines for inhibition of NCp7 and hepatitis C viruses
dc.title.alternativeRazrabotka novikh lekarstvennikh sredstv dlya ingibitsii virusov NCp7 i gepatita C
dc.typeText
dcterms.creatorhttps://orcid.org/0000-0002-0154-3459

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
50032228.pdf
Size:
500.63 KB
Format:
Adobe Portable Document Format